Masimo Corporation (0JZ2.L)

USD 172.78

(-1.63%)

Operating Expenses Summary of Masimo Corporation

  • Masimo Corporation's latest annual operating expenses in 2023 was 867 Million USD , down -1.13% from previous year.
  • Masimo Corporation's latest quarterly operating expenses in 2024 Q3 was 233.1 Million USD , up 2.91% from previous quarter.
  • Masimo Corporation reported a annual operating expenses of 848.8 Million USD in annual operating expenses 2022, up 59.39% from previous year.
  • Masimo Corporation reported a annual operating expenses of 532.52 Million USD in annual operating expenses 2021, up 9.19% from previous year.
  • Masimo Corporation reported a quarterly operating expenses of 207.7 Million USD for 2024 Q1, up 5.01% from previous quarter.
  • Masimo Corporation reported a quarterly operating expenses of 226.5 Million USD for 2024 Q2, up 9.05% from previous quarter.

Annual Operating Expenses Chart of Masimo Corporation (2023 - 1998)

Historical Annual Operating Expenses of Masimo Corporation (2023 - 1998)

Year Operating Expenses Operating Expenses Growth
2023 867 Million USD -1.13%
2022 848.8 Million USD 59.39%
2021 532.52 Million USD 9.19%
2020 487.71 Million USD 19.55%
2019 407.95 Million USD 11.33%
2018 366.42 Million USD 8.49%
2017 337.73 Million USD 7.89%
2016 313.02 Million USD 1.19%
2015 309.34 Million USD 3.95%
2014 297.59 Million USD 9.77%
2013 271.1 Million USD 12.48%
2012 241.02 Million USD 16.09%
2011 207.61 Million USD 15.75%
2010 179.36 Million USD 7.68%
2009 166.57 Million USD 13.88%
2008 146.27 Million USD 26.39%
2007 115.73 Million USD 179.14%
2006 -146.23 Million USD -374.01%
2005 53.36 Million USD 0.0%
2004 - USD -100.0%
2003 30.75 Million USD 52.85%
2002 20.12 Million USD 0.0%
1999 13.79 Million USD 97.14%
1998 7 Million USD 0.0%

Peer Operating Expenses Comparison of Masimo Corporation

Name Operating Expenses Operating Expenses Difference
Phreesia, Inc. 369.84 Million USD -134.425%
Accuray Incorporated 142.61 Million USD -507.922%
Align Technology, Inc. 2.07 Billion USD 58.254%
Elevance Health Inc. 36.23 Billion USD 97.607%
AxoGen, Inc. 149.33 Million USD -480.57%
Boston Scientific Corporation 7.5 Billion USD 88.449%
CVS Health Corporation 40.68 Billion USD 97.869%
Cardinal Health, Inc. 5 Billion USD 82.66%
Centene Corporation 138.33 Billion USD 99.373%
DaVita Inc. 1.47 Billion USD 41.18%
HCA Healthcare, Inc. 45.43 Billion USD 98.092%
Hologic, Inc. 1.26 Billion USD 31.603%
Humana Inc. 102.36 Billion USD 99.153%
IDEXX Laboratories, Inc. 1.09 Billion USD 20.666%
Laboratory Corporation of America Holdings 2.02 Billion USD 57.109%
McKesson Corporation 8.67 Billion USD 90.006%
Patterson Companies, Inc. 1.12 Billion USD 23.092%
Quest Diagnostics Incorporated 1.61 Billion USD 46.149%
ResMed Inc. 1.36 Billion USD 36.64%
Henry Schein, Inc. 2.93 Billion USD 70.48%
Teladoc Health, Inc. 2.09 Billion USD 58.535%
Universal Health Services, Inc. 9.2 Billion USD 90.585%
Veeva Systems Inc. 1.25 Billion USD 31.029%
Baxter International Inc. 5.27 Billion USD 83.555%
Becton, Dickinson and Company 6.71 Billion USD 87.083%
Intuitive Surgical, Inc. 2.96 Billion USD 70.736%
Danaher Corporation 8.75 Billion USD 90.097%
Stryker Corporation 9.2 Billion USD 90.585%
Medtronic plc 16.12 Billion USD 94.625%